Hoffmann-La Roche Granted Amino-Pyrimidine Amide Patent US12600712B2

USPTO granted Patent US12600712B2 to Hoffmann-La Roche Inc. for novel amino-pyrimidine amide compounds of general formula (I), where R1-R5 are defined in the patent. The patent covers compositions including these compounds and methods of using them. The invention was filed on December 7, 2022, and formally granted on April 14, 2026.

For pharmaceutical companies and drug manufacturers, this patent establishes exclusive rights for Hoffmann-La Roche in the United States for amino-pyrimidine amide compositions and methods. Parties seeking to develop, manufacture, or commercialize similar compounds may need to consider licensing or design-around strategies to avoid infringement.